Biomarin Pharmaceutical Inc financial data

Symbol
BMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
105 Digital Drive, Novato, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 303 % -22.4%
Quick Ratio 114 % -12.2%
Debt-to-equity 33.3 % -12.2%
Return On Equity 6.22 % +100%
Return On Assets 4.67 % +107%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 191M shares +1.18%
Common Stock, Shares, Outstanding 191M shares +1.18%
Entity Public Float 10.1B USD +12.2%
Common Stock, Value, Issued 191K USD +1.6%
Weighted Average Number of Shares Outstanding, Basic 190M shares +1.17%
Weighted Average Number of Shares Outstanding, Diluted 197M shares +3.13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.75B USD +19.1%
Cost of Revenue 565M USD +8.32%
Research and Development Expense 780M USD +9.34%
Costs and Expenses 2.43B USD +11.7%
Operating Income (Loss) 322M USD +141%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 391M USD +158%
Income Tax Expense (Benefit) 69.2M USD +1385%
Net Income (Loss) Attributable to Parent 322M USD +119%
Earnings Per Share, Basic 1.7 USD/shares +121%
Earnings Per Share, Diluted 1.66 USD/shares +113%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 675M USD -14%
Accounts Receivable, after Allowance for Credit Loss, Current 778M USD +35.8%
Inventory, Net 1.18B USD +14.3%
Other Assets, Current 169M USD -24.7%
Assets, Current 3.06B USD +3.43%
Deferred Income Tax Assets, Net 1.53B USD +0.45%
Property, Plant and Equipment, Net 1.05B USD -2.04%
Operating Lease, Right-of-Use Asset 42.7M USD +22.3%
Intangible Assets, Net (Excluding Goodwill) 261M USD -13.7%
Goodwill 196M USD 0%
Other Assets, Noncurrent 199M USD +20.7%
Assets 6.85B USD +1.38%
Employee-related Liabilities, Current 200M USD +14.3%
Contract with Customer, Liability, Current 2.35M USD
Liabilities, Current 716M USD -38.5%
Operating Lease, Liability, Noncurrent 38M USD +44.5%
Other Liabilities, Noncurrent 128M USD +20.9%
Liabilities 1.44B USD -22.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.65M USD -25.7%
Retained Earnings (Accumulated Deficit) -320M USD +50.2%
Stockholders' Equity Attributable to Parent 5.41B USD +10.5%
Liabilities and Equity 6.85B USD +1.38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 47M USD
Net Cash Provided by (Used in) Financing Activities -42.8M USD -5.03%
Net Cash Provided by (Used in) Investing Activities -14.2M USD +52.6%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 191M shares +1.18%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.13M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 675M USD -14%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42M USD -1.18%
Deferred Tax Assets, Valuation Allowance 119M USD +2.52%
Operating Lease, Liability 46.7M USD +35.7%
Depreciation 45.7M USD +19.3%
Payments to Acquire Property, Plant, and Equipment 26.1M USD +6.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 321M USD +162%
Lessee, Operating Lease, Liability, to be Paid 58.4M USD +46.9%
Property, Plant and Equipment, Gross 1.91B USD -0.21%
Operating Lease, Liability, Current 8.64M USD +6.83%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.86M USD +30%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2M USD +15.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.6%
Deferred Income Tax Expense (Benefit) 285K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.7M USD +119%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.97M USD +33.7%
Deferred Tax Assets, Operating Loss Carryforwards 19M USD -7.9%
Unrecognized Tax Benefits 277M USD +19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.06M USD +41.9%
Amortization of Intangible Assets 5.01M USD -68.1%
Depreciation, Depletion and Amortization 27.4M USD +3.52%
Deferred Tax Assets, Net of Valuation Allowance 1.62B USD +2.77%
Share-based Payment Arrangement, Expense 205M USD +2.78%
Interest Expense 17.2M USD +8.27%